135 related articles for article (PubMed ID: 16790816)
21. Innate and cell-mediated immune responses to Cryptosporidium parvum.
Theodos CM
Adv Parasitol; 1998; 40():87-119. PubMed ID: 9554071
[TBL] [Abstract][Full Text] [Related]
22. Dynamics of cytokines and immunoglobulins serum profiles in primary and secondary Cryptosporidium parvum infection: usefulness of Luminex® xMAP technology.
Codices V; Martins C; Novo C; de Sousa B; Lopes Â; Borrego M; Matos O
Exp Parasitol; 2013 Jan; 133(1):106-13. PubMed ID: 23178641
[TBL] [Abstract][Full Text] [Related]
23. Intestinal CD103+ dendritic cells are key players in the innate immune control of Cryptosporidium parvum infection in neonatal mice.
Lantier L; Lacroix-Lamandé S; Potiron L; Metton C; Drouet F; Guesdon W; Gnahoui-David A; Le Vern Y; Deriaud E; Fenis A; Rabot S; Descamps A; Werts C; Laurent F
PLoS Pathog; 2013; 9(12):e1003801. PubMed ID: 24367259
[TBL] [Abstract][Full Text] [Related]
24. Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice.
Chen W; Harp JA; Harmsen AG; Havell EA
Infect Immun; 1993 Aug; 61(8):3548-51. PubMed ID: 8335387
[TBL] [Abstract][Full Text] [Related]
25. Adoptive transfer of protective immunity from Cryptosporidium parvum-infected interferon-gamma and interleukin-12-deficient mice to naive recipients.
Tessema TS; Dauber E; Petry F
Vaccine; 2009 Nov; 27(47):6575-81. PubMed ID: 19717136
[TBL] [Abstract][Full Text] [Related]
26. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection.
Aguirre SA; Perryman LE; Davis WC; McGuire TC
J Immunol; 1998 Aug; 161(4):1891-900. PubMed ID: 9712058
[TBL] [Abstract][Full Text] [Related]
27. Protection against the early acute phase of Cryptosporidium parvum infection conferred by interleukin-4-induced expression of T helper 1 cytokines.
McDonald SA; O'Grady JE; Bajaj-Elliott M; Notley CA; Alexander J; Brombacher F; McDonald V
J Infect Dis; 2004 Sep; 190(5):1019-25. PubMed ID: 15295711
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of spleen and Peyer's patch lymphocyte populations during gut parasite clearing in Cryptosporidium parvum infected suckling mice.
Mariotte D; Comby E; Brasseur P; Ballet JJ
Parasite Immunol; 2004 Jan; 26(1):1-6. PubMed ID: 15198640
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection.
Zaalouk TK; Bajaj-Elliott M; George JT; McDonald V
Infect Immun; 2004 May; 72(5):2772-9. PubMed ID: 15102787
[TBL] [Abstract][Full Text] [Related]
30. B cells are required for the induction of intestinal inflammatory lesions in TCRalpha-deficient mice persistently infected with Cryptosporidium parvum.
Waters WR; Palmer MV; Wannemuehler MJ; Sacco RE; Harp JA
J Parasitol; 2000 Oct; 86(5):1073-7. PubMed ID: 11128483
[TBL] [Abstract][Full Text] [Related]
31. CCL20 Displays Antimicrobial Activity Against Cryptosporidium parvum, but Its Expression Is Reduced During Infection in the Intestine of Neonatal Mice.
Guesdon W; Auray G; Pezier T; Bussière FI; Drouet F; Le Vern Y; Marquis M; Potiron L; Rabot S; Bruneau A; Werts C; Laurent F; Lacroix-Lamandé S
J Infect Dis; 2015 Oct; 212(8):1332-40. PubMed ID: 25838265
[TBL] [Abstract][Full Text] [Related]
32. Protection from Cryptosporidium parvum infection by gammadelta T cells in mice that lack alphabeta T cells.
Eichelberger MC; Suresh P; Rehg JE
Comp Med; 2000 Jun; 50(3):270-6. PubMed ID: 10894490
[TBL] [Abstract][Full Text] [Related]
33. Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8.
Seydel KB; Zhang T; Champion GA; Fichtenbaum C; Swanson PE; Tzipori S; Griffiths JK; Stanley SL
Infect Immun; 1998 May; 66(5):2379-82. PubMed ID: 9573136
[TBL] [Abstract][Full Text] [Related]
34. A potential role for interleukin-18 in inhibition of the development of Cryptosporidium parvum.
McDonald V; Pollok RC; Dhaliwal W; Naik S; Farthing MJ; Bajaj-Elliott M
Clin Exp Immunol; 2006 Sep; 145(3):555-62. PubMed ID: 16907926
[TBL] [Abstract][Full Text] [Related]
35. Cryptosporidium parvum increases intestinal permeability through interaction with epithelial cells and IL-1β and TNFα released by inflammatory monocytes.
de Sablet T; Potiron L; Marquis M; Bussière FI; Lacroix-Lamandé S; Laurent F
Cell Microbiol; 2016 Dec; 18(12):1871-1880. PubMed ID: 27324279
[TBL] [Abstract][Full Text] [Related]
36. Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice.
Cosyns M; Tsirkin S; Jones M; Flavell R; Kikutani H; Hayward AR
Infect Immun; 1998 Feb; 66(2):603-7. PubMed ID: 9453615
[TBL] [Abstract][Full Text] [Related]
37. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
38. Cryptosporidium parvum biliary tract infection in adult immunocompetent and immunosuppressed mice.
Verdon R; Polianski J; Grodet A; Garry L; Carbon C
J Med Microbiol; 1998 Jan; 47(1):71-7. PubMed ID: 9449952
[TBL] [Abstract][Full Text] [Related]
39. Enterocyte-innate lymphoid cell crosstalk drives early IFN-γ-mediated control of Cryptosporidium.
Gullicksrud JA; Sateriale A; Engiles JB; Gibson AR; Shaw S; Hutchins ZA; Martin L; Christian DA; Taylor GA; Yamamoto M; Beiting DP; Striepen B; Hunter CA
Mucosal Immunol; 2022 Feb; 15(2):362-372. PubMed ID: 34750455
[TBL] [Abstract][Full Text] [Related]
40. Binding and activation of human and mouse complement by Cryptosporidium parvum (Apicomplexa) and susceptibility of C1q- and MBL-deficient mice to infection.
Petry F; Jakobi V; Wagner S; Tessema TS; Thiel S; Loos M
Mol Immunol; 2008 Jul; 45(12):3392-400. PubMed ID: 18501966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
